,Diagnosis,Treatment code,Diagnosis code,case Specialism code,Diagnosis Treatment Combination ID,Age,Case ID,Activity,Producer code,Section,Specialism code,group,Number of executions,Complete Timestamp,duration,month,weekday,hour,remtime,elapsed,case_length
337,maligniteit cervix,TC3201,DC822,SC7,DTC395310,52.0,2,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2005-01-03 09:00:00,0.0,1.0,0.0,9.0,69811200.0,0.0,1
1202,maligniteit ovarium | tuba,TC101,M16,SC7,other,71.0,9,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-08 09:00:00,0.0,1.0,5.0,9.0,8640000.0,0.0,1
1426,maligniteit cervix,TC113,M13,SC61,DTC229311,83.0,10,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-10 09:00:00,0.0,1.0,0.0,9.0,12873600.0,0.0,1
1543,maligniteit ovarium | tuba,TC603,M16,SC7,DTC154699,72.0,11,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2005-01-10 09:00:00,0.0,1.0,0.0,9.0,2764800.0,0.0,1
2531,Maligne neoplasma cervix uteri,TC32,DC106,SC13,DTC165717,41.0,12,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2005-01-11 09:00:00,0.0,1.0,1.0,9.0,98668800.0,0.0,1
2976,maligniteit vulva,TC813,M11,SC7,DTC156193,84.0,14,AC355427,LVPT,Section 4,SC88,Pathology,1.0,2005-01-12 09:00:00,0.0,1.0,2.0,9.0,90115200.0,0.0,1
3017,maligniteit vulva,TC101,M11,SC7,DTC55501,55.0,15,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-12 09:00:00,0.0,1.0,2.0,9.0,97977600.0,0.0,1
3021,Gynaecologische tumoren,TC61,DC106,SC7,other,79.0,16,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-12 09:00:00,0.0,1.0,2.0,9.0,52099200.0,0.0,1
3139,maligniteit ovarium | tuba,TC803,M16,SC7,DTC156083,53.0,17,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-01-12 09:00:00,0.0,1.0,2.0,9.0,1987200.0,0.0,1
3267,maligniteit ovarium | tuba,TC803,M16,SC7,DTC156150,73.0,18,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2005-01-12 09:00:00,0.0,1.0,2.0,9.0,2073600.0,0.0,1
3410,maligniteit cervix,TC113,DC822,SC61,DTC177135,86.0,20,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-01-13 09:00:00,0.0,1.0,3.0,9.0,39052800.0,0.0,1
4788,maligniteit cervix,TC101,M13,SC7,DTC161617,51.0,25,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2005-01-19 09:00:00,0.0,1.0,2.0,9.0,37324800.0,0.0,1
4907,maligniteit ovarium | tuba,TC101,M16,SC7,other,63.0,28,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-19 09:00:00,0.0,1.0,2.0,9.0,39398400.0,0.0,1
5045,maligniteit ovarium | tuba,TC101,M16,SC7,DTC238155,71.0,29,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-21 09:00:00,0.0,1.0,4.0,9.0,93571200.0,0.0,1
5811,maligniteit myometrium,TC101,M15,SC7,DTC270518,36.0,34,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-29 09:00:00,0.0,1.0,5.0,9.0,98841600.0,0.0,1
6346,maligniteit ovarium | tuba,TC101,M16,SC7,DTC169839,59.0,38,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-02-02 09:00:00,0.0,2.0,2.0,9.0,97286400.0,0.0,1
6652,maligniteit vulva,TC101,M11,SC7,DTC179034,77.0,41,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-02-03 09:00:00,0.0,2.0,3.0,9.0,93139200.0,0.0,1
6664,maligniteit cervix,TC101,M13,SC7,other,32.0,42,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-03 09:00:00,0.0,2.0,3.0,9.0,25315200.0,0.0,1
6852,maligniteit endometrium,TC101,M14,SC7,DTC247860,65.0,44,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-04 09:00:00,0.0,2.0,4.0,9.0,68169600.0,0.0,1
7483,maligniteit ovarium | tuba,TC803,M16,SC7,DTC172686,65.0,48,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-02-07 09:00:00,0.0,2.0,0.0,9.0,10454400.0,0.0,1
8134,maligniteit cervix,TC803,M13,SC7,DTC175314,41.0,58,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-02-10 09:00:00,0.0,2.0,3.0,9.0,6566400.0,0.0,1
8172,maligniteit ovarium | tuba,TC603,M16,SC7,DTC140498,48.0,59,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2005-02-10 09:00:00,0.0,2.0,3.0,9.0,4233600.0,0.0,1
8200,maligniteit vulva,TC101,M11,SC7,other,84.0,61,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-12 09:00:00,0.0,2.0,5.0,9.0,26956800.0,0.0,1
8367,maligniteit cervix,TC9101,DC822,SC13,DTC177222,39.0,62,AC419100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2005-02-14 09:00:00,0.0,2.0,0.0,9.0,31017600.0,0.0,1
9148,maligniteit myometrium,TC103,M15,SC7,DTC177951,56.0,64,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-02-15 09:00:00,0.0,2.0,1.0,9.0,1296000.0,0.0,1
11123,maligniteit vulva,TC101,M11,SC7,DTC217629,73.0,73,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-18 09:00:00,0.0,2.0,4.0,9.0,94176000.0,0.0,1
11131,Gynaecologische tumoren,TC61,DC106,SC7,other,43.0,74,AC10307,SGEH,Section 2,SC7,Nursing ward,1.0,2005-02-18 09:00:00,0.0,2.0,4.0,9.0,51321600.0,0.0,1
11996,Recidieven (pre)maligniteit cervix uteri (ov),TC103,M13,SC13,DTC392290,45.0,76,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-02-21 09:00:00,0.0,2.0,0.0,9.0,92966400.0,0.0,1
13157,maligniteit ovarium,TC803,DC821,SC13,DTC215099,71.0,77,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-02-21 09:00:00,0.0,2.0,0.0,9.0,96163200.0,0.0,1
13580,maligniteit cervix,TC101,M13,SC7,other,48.0,82,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2005-02-24 09:00:00,0.0,2.0,3.0,9.0,41731200.0,0.0,1
13597,maligniteit ovarium | tuba,TC101,M16,SC7,other,57.0,84,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2005-02-24 09:00:00,0.0,2.0,3.0,9.0,64713600.0,0.0,1
13610,maligniteit cervix,TC101,M13,SC7,other,44.0,86,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-28 09:00:00,0.0,2.0,0.0,9.0,0.0,0.0,1
14657,maligniteit cervix,TC103,M13,SC61,DTC201794,43.0,88,AC410100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2005-02-28 09:00:00,0.0,2.0,0.0,9.0,15379200.0,0.0,1
14748,maligniteit ovarium | tuba,TC803,M16,SC7,DTC187204,58.0,89,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-02 09:00:00,0.0,3.0,2.0,9.0,29030400.0,0.0,1
15201,maligniteit ovarium | tuba,TC803,DC821,SC7,DTC187241,63.0,90,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-02 09:00:00,0.0,3.0,2.0,9.0,95472000.0,0.0,1
16195,maligniteit cervix,TC61,DC822,SC61,DTC232764,71.0,97,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-07 09:00:00,0.0,3.0,0.0,9.0,94435200.0,0.0,1
17067,Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC207533,69.0,100,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-07 09:00:00,0.0,3.0,0.0,9.0,95126400.0,0.0,1
17086,maligniteit cervix,TC101,M13,SC7,DTC222842,52.0,101,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-08 09:00:00,0.0,3.0,1.0,9.0,92707200.0,0.0,1
17593,maligniteit cervix,TC101,M13,SC7,other,51.0,108,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-10 09:00:00,0.0,3.0,3.0,9.0,63504000.0,0.0,1
17613,maligniteit ovarium | tuba,TC101,M16,SC7,DTC203747,47.0,109,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-11 09:00:00,0.0,3.0,4.0,9.0,65232000.0,0.0,1
17736,maligniteit vulva,TC101,M11,SC7,other,77.0,111,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-14 09:00:00,0.0,3.0,0.0,9.0,49593600.0,0.0,1
17886,Gynaecologische tumoren,TC61,DC106,SC7,DTC309350,45.0,113,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-15 09:00:00,0.0,3.0,1.0,9.0,59529600.0,0.0,1
19593,Maligne neoplasma adnexa uteri,TC101,DC839,SC13,DTC464231,57.0,119,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-16 09:00:00,0.0,3.0,2.0,9.0,94176000.0,0.0,1
19686,maligniteit vulva,TC101,M11,SC7,other,91.0,121,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-17 09:00:00,0.0,3.0,3.0,9.0,23500800.0,0.0,1
19960,Gynaecologische tumoren,TC12,DC106,SC61,DTC390635,62.0,124,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-17 09:00:00,0.0,3.0,3.0,9.0,57456000.0,0.0,1
20283,maligniteit cervix,TC103,DC822,SC61,DTC224693,58.0,127,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-23 09:00:00,0.0,3.0,2.0,9.0,55036800.0,0.0,1
20371,Gynaecologische tumoren,TC61,DC106,SC7,DTC310159,47.0,129,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-23 09:00:00,0.0,3.0,2.0,9.0,93571200.0,0.0,1
21802,maligniteit vulva,TC101,M11,SC7,DTC200214,70.0,133,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-24 09:00:00,0.0,3.0,3.0,9.0,84067200.0,0.0,1
22746,Maligne neoplasma cervix uteri,TC103,DC822,SC61,DTC402035,39.0,139,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-27 09:00:00,0.0,3.0,6.0,9.0,70416000.0,0.0,1
22825,maligniteit endometrium,TC613,M14,SC7,DTC246929,51.0,140,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2005-03-29 09:00:00,0.0,3.0,1.0,9.0,6480000.0,0.0,1
22841,maligniteit vulva,TC101,M11,SC7,other,73.0,141,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-30 09:00:00,0.0,3.0,2.0,9.0,32054400.0,0.0,1
23115,maligniteit cervix,TC101,M13,SC7,other,38.0,147,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-30 09:00:00,0.0,3.0,2.0,9.0,0.0,0.0,1
23251,maligniteit ovarium | tuba,TC101,M16,SC7,DTC203111,63.0,150,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-30 09:00:00,0.0,3.0,2.0,9.0,89424000.0,0.0,1
23471,Gynaecologische tumoren,TC61,DC106,SC7,DTC205671,46.0,158,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-04 09:00:00,0.0,4.0,0.0,9.0,50803200.0,0.0,1
23555,maligniteit cervix,TC101,M13,SC7,other,39.0,162,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-06 09:00:00,0.0,4.0,2.0,9.0,64108800.0,0.0,1
23692,maligniteit vulva,TC101,M11,SC7,other,67.0,164,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-07 09:00:00,0.0,4.0,3.0,9.0,89424000.0,0.0,1
23838,Gynaecologische tumoren,TC61,DC106,SC7,DTC208337,46.0,167,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2005-04-07 09:00:00,0.0,4.0,3.0,9.0,79574400.0,0.0,1
24238,Gynaecologische tumoren,TC61,DC106,SC7,other,71.0,174,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-13 09:00:00,0.0,4.0,2.0,9.0,48470400.0,0.0,1
24332,maligniteit cervix,TC813,M13,SC7,DTC212333,45.0,175,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-04-13 09:00:00,0.0,4.0,2.0,9.0,8467200.0,0.0,1
24362,maligniteit cervix,TC101,M13,SC7,other,49.0,176,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-13 09:00:00,0.0,4.0,2.0,9.0,0.0,0.0,1
24521,maligniteit ovarium | tuba,TC101,M16,SC7,DTC229523,60.0,181,AC10307,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-17 09:00:00,0.0,4.0,6.0,9.0,91065600.0,0.0,1
24556,maligniteit cervix,TC101,M13,SC7,other,54.0,184,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-19 09:00:00,0.0,4.0,1.0,9.0,11577600.0,0.0,1
24606,maligniteit cervix,TC61,DC106,SC61,other,85.0,187,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-20 09:00:00,0.0,4.0,2.0,9.0,79315200.0,0.0,1
24630,maligniteit ovarium | tuba,TC101,M16,SC7,DTC217675,69.0,189,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-04-21 09:00:00,0.0,4.0,3.0,9.0,85881600.0,0.0,1
25304,Plav.celcarc. vulva: st I,TC101,M11,SC7,DTC220052,79.0,192,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-25 09:00:00,0.0,4.0,0.0,9.0,83462400.0,0.0,1
26045,maligniteit cervix,TC813,DC822,SC61,DTC264024,43.0,194,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-04-25 09:00:00,0.0,4.0,0.0,9.0,38275200.0,0.0,1
26363,maligniteit ovarium | tuba,TC3101,DC822,SC13,DTC293450,59.0,195,370701S,CRPO,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-04-25 09:00:00,0.0,4.0,0.0,9.0,30326400.0,0.0,1
26554,maligniteit cervix,TC103,M13,SC7,DTC222012,58.0,198,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-04-27 09:00:00,0.0,4.0,2.0,9.0,7862400.0,0.0,1
26990,maligniteit cervix,TC61,DC106,SC61,DTC392371,26.0,199,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-04-27 09:00:00,0.0,4.0,2.0,9.0,17625600.0,0.0,1
27050,maligniteit cervix,TC510,M13,SC7,DTC221936,43.0,200,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-04-27 09:00:00,0.0,4.0,2.0,9.0,12096000.0,0.0,1
27099,maligniteit cervix,TC101,M13,SC7,DTC221377,42.0,202,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-27 09:00:00,0.0,4.0,2.0,9.0,50976000.0,0.0,1
27199,Gynaecologische tumoren,TC61,DC106,SC7,DTC226309,50.0,207,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-04 09:00:00,0.0,5.0,2.0,9.0,48816000.0,0.0,1
27207,Gynaecologische tumoren,TC61,DC106,SC7,other,42.0,208,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-04 09:00:00,0.0,5.0,2.0,9.0,78105600.0,0.0,1
28268,maligniteit endometrium,TC3101,DC823,SC7,DTC227929,64.0,210,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-09 09:00:00,0.0,5.0,0.0,9.0,39484800.0,0.0,1
28345,maligniteit vulva,TC101,M11,SC7,DTC273249,57.0,211,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-10 09:00:00,0.0,5.0,1.0,9.0,87868800.0,0.0,1
28458,maligniteit cervix,TC101,M13,SC7,DTC229555,33.0,216,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-11 09:00:00,0.0,5.0,2.0,9.0,82252800.0,0.0,1
29066,maligniteit cervix,TC61,DC106,SC61,other,53.0,221,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-14 09:00:00,0.0,5.0,5.0,9.0,58492800.0,0.0,1
29078,maligniteit cervix,TC61,DC106,SC61,DTC803549,61.0,222,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-16 09:00:00,0.0,5.0,0.0,9.0,49248000.0,0.0,1
29156,Gynaecologische tumoren,TC13,DC106,SC61,DTC787870,70.0,223,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-16 09:00:00,0.0,5.0,0.0,9.0,61344000.0,0.0,1
29165,maligniteit vulva,TC101,M11,SC7,DTC233586,73.0,224,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-18 09:00:00,0.0,5.0,2.0,9.0,79833600.0,0.0,1
29180,Gynaecologische tumoren,TC61,DC106,SC7,other,72.0,226,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-18 09:00:00,0.0,5.0,2.0,9.0,62899200.0,0.0,1
29183,maligniteit cervix,TC101,M13,SC7,other,40.0,227,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-18 09:00:00,0.0,5.0,2.0,9.0,34473600.0,0.0,1
29949,maligniteit vulva,TC101,M11,SC7,other,73.0,230,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-21 09:00:00,0.0,5.0,5.0,9.0,60220800.0,0.0,1
30049,maligniteit endometrium,TC101,M14,SC7,DTC246740,55.0,232,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-23 09:00:00,0.0,5.0,0.0,9.0,81129600.0,0.0,1
30894,maligniteit vulva,TC101,M11,SC7,other,58.0,235,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-25 09:00:00,0.0,5.0,2.0,9.0,0.0,0.0,1
32021,maligniteit endometrium,TC101,M14,SC7,other,73.0,242,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-26 09:00:00,0.0,5.0,3.0,9.0,75600000.0,0.0,1
32205,maligniteit cervix,TC101,M13,SC7,DTC241211,56.0,245,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-05-30 09:00:00,0.0,5.0,0.0,9.0,87436800.0,0.0,1
32532,Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC268936,36.0,246,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-05-30 09:00:00,0.0,5.0,0.0,9.0,87868800.0,0.0,1
33349,maligniteit ovarium | tuba,TC803,M16,SC7,DTC243184,68.0,250,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-01 09:00:00,0.0,6.0,2.0,9.0,8899200.0,0.0,1
33513,Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC250610,51.0,253,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-06-02 09:00:00,0.0,6.0,3.0,9.0,41126400.0,0.0,1
34293,maligniteit ovarium | tuba,TC103,M16,SC61,DTC301600,82.0,260,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-06-08 09:00:00,0.0,6.0,2.0,9.0,8640000.0,0.0,1
34353,maligniteit endometrium,TC101,M14,SC7,DTC290856,55.0,263,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-09 09:00:00,0.0,6.0,3.0,9.0,55036800.0,0.0,1
34542,maligniteit ovarium | tuba,TC603,M16,SC7,DTC254438,70.0,266,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-06-13 09:00:00,0.0,6.0,0.0,9.0,1468800.0,0.0,1
34607,Gynaecologische tumoren,TC62,DC106,SC7,DTC315045,42.0,268,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-14 09:00:00,0.0,6.0,1.0,9.0,60393600.0,0.0,1
34625,maligniteit ovarium | tuba,TC101,M16,SC7,DTC251292,41.0,269,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-14 09:00:00,0.0,6.0,1.0,9.0,73180800.0,0.0,1
34913,maligniteit endometrium,TC101,M14,SC7,other,68.0,271,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-15 09:00:00,0.0,6.0,2.0,9.0,67737600.0,0.0,1
34960,maligniteit cervix,TC101,M13,SC7,other,45.0,274,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-16 09:00:00,0.0,6.0,3.0,9.0,0.0,0.0,1
34973,Gynaecologische tumoren,TC13,DC106,SC7,DTC253037,77.0,275,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-16 09:00:00,0.0,6.0,3.0,9.0,82252800.0,0.0,1
35075,Gynaecologische tumoren,TC61,DC106,SC7,DTC449929,50.0,278,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-06-20 09:00:00,0.0,6.0,0.0,9.0,68947200.0,0.0,1
35172,maligniteit vulva,TC101,M11,SC7,DTC256757,80.0,280,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-22 09:00:00,0.0,6.0,2.0,9.0,84758400.0,0.0,1
35676,maligniteit cervix,TC101,M13,SC7,other,69.0,289,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-29 09:00:00,0.0,6.0,2.0,9.0,0.0,0.0,1
35942,maligniteit endometrium,TC101,M14,SC61,DTC390356,59.0,293,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-06-29 09:00:00,0.0,6.0,2.0,9.0,81734400.0,0.0,1
36565,Maligne neoplasma cervix uteri,TC61,DC822,SC61,DTC297647,50.0,296,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-06-30 09:00:00,0.0,6.0,3.0,9.0,84067200.0,0.0,1
36614,maligniteit ovarium | tuba,TC101,M16,SC7,DTC270582,59.0,298,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-02 09:00:00,0.0,7.0,5.0,9.0,1555200.0,0.0,1
36705,maligniteit vulva,TC603,M11,SC7,DTC263801,80.0,299,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-03 09:00:00,0.0,7.0,6.0,9.0,70502400.0,0.0,1
37170,maligniteit endometrium,TC103,M14,SC7,DTC549031,54.0,303,370488T,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-04 09:00:00,0.0,7.0,0.0,9.0,691200.0,0.0,1
37223,maligniteit vulva,TC101,M11,SC7,other,84.0,305,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-06 09:00:00,0.0,7.0,2.0,9.0,24192000.0,0.0,1
37265,maligniteit cervix,TC603,M13,SC7,DTC266024,52.0,306,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-06 09:00:00,0.0,7.0,2.0,9.0,76723200.0,0.0,1
37307,maligniteit ovarium | tuba,TC101,M16,SC7,other,59.0,308,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-06 09:00:00,0.0,7.0,2.0,9.0,72576000.0,0.0,1
37604,maligniteit vulva,TC503,M11,SC7,DTC266947,74.0,311,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-07 09:00:00,0.0,7.0,3.0,9.0,5356800.0,0.0,1
37646,maligniteit endometrium,TC101,M14,SC7,DTC322180,69.0,314,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-08 09:00:00,0.0,7.0,4.0,9.0,80784000.0,0.0,1
37974,maligniteit cervix,TC103,M13,SC7,DTC274807,41.0,317,370402S,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-12 09:00:00,0.0,7.0,1.0,9.0,1987200.0,0.0,1
38016,Gynaecologische tumoren,TC61,DC106,SC7,other,63.0,318,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-12 09:00:00,0.0,7.0,1.0,9.0,58838400.0,0.0,1
38023,Gynaecologische tumoren,TC61,DC106,SC7,other,80.0,319,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-12 09:00:00,0.0,7.0,1.0,9.0,62208000.0,0.0,1
38262,maligniteit cervix,TC101,M13,SC7,other,52.0,324,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-14 09:00:00,0.0,7.0,3.0,9.0,68256000.0,0.0,1
39109,maligniteit vulva,TC101,M11,SC7,other,73.0,331,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-20 09:00:00,0.0,7.0,2.0,9.0,71366400.0,0.0,1
39868,Gynaecologische tumoren,TC101,DC106,SC61,DTC785776,85.0,332,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-20 09:00:00,0.0,7.0,2.0,9.0,82857600.0,0.0,1
39963,Maligne neoplasma vulva,TC3104,DC839,SC7,DTC275114,85.0,333,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-20 09:00:00,0.0,7.0,2.0,9.0,35683200.0,0.0,1
40011,maligniteit vagina,TC101,M12,SC7,DTC274946,42.0,334,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-20 09:00:00,0.0,7.0,2.0,9.0,49593600.0,0.0,1
40297,maligniteit ovarium | tuba,TC101,M16,SC7,DTC274937,64.0,335,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-20 09:00:00,0.0,7.0,2.0,9.0,81043200.0,0.0,1
40336,Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC281540,51.0,336,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-07-21 09:00:00,0.0,7.0,3.0,9.0,57196800.0,0.0,1
40380,maligniteit ovarium | tuba,TC101,M16,SC7,DTC322089,37.0,338,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-22 09:00:00,0.0,7.0,4.0,9.0,7776000.0,0.0,1
42551,Maligne neoplasma cervix uteri,TC101,DC822,SC61,DTC560924,32.0,345,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-28 09:00:00,0.0,7.0,3.0,9.0,58579200.0,0.0,1
42615,maligniteit cervix,TC101,DC106,SC7,DTC281429,73.0,346,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-28 09:00:00,0.0,7.0,3.0,9.0,72576000.0,0.0,1
42859,maligniteit cervix,TC101,M13,SC7,other,65.0,352,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-02 09:00:00,0.0,8.0,1.0,9.0,33955200.0,0.0,1
42879,maligniteit endometrium,TC101,M14,SC7,DTC333715,43.0,353,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-02 09:00:00,0.0,8.0,1.0,9.0,66096000.0,0.0,1
43591,maligniteit vulva,TC813,M11,SC7,DTC285249,84.0,358,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-08-08 09:00:00,0.0,8.0,0.0,9.0,73353600.0,0.0,1
43749,maligniteit cervix,TC101,M13,SC7,other,67.0,361,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-11 09:00:00,0.0,8.0,3.0,9.0,10800000.0,0.0,1
43756,maligniteit cervix,TC101,M13,SC7,other,48.0,362,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-13 09:00:00,0.0,8.0,5.0,9.0,74044800.0,0.0,1
44209,Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC390872,79.0,365,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-08-17 09:00:00,0.0,8.0,2.0,9.0,62726400.0,0.0,1
44239,Maligne nieuwvormingen ovarium (ov),TC101,M16,SC7,DTC291148,27.0,366,other,SLVE,Section 4,SC86,Special lab radiology,1.0,2005-08-17 09:00:00,0.0,8.0,2.0,9.0,73785600.0,0.0,1
44692,Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC332203,39.0,371,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-23 09:00:00,0.0,8.0,1.0,9.0,63590400.0,0.0,1
44776,maligniteit cervix,TC101,M13,SC7,DTC319529,52.0,373,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-23 09:00:00,0.0,8.0,1.0,9.0,81043200.0,0.0,1
45101,Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC317582,45.0,374,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-08-24 09:00:00,0.0,8.0,2.0,9.0,32400000.0,0.0,1
46804,Maligne neoplasma ovarium,TC3101,DC821,SC13,DTC297667,54.0,377,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-08-24 09:00:00,0.0,8.0,2.0,9.0,57024000.0,0.0,1
48013,maligniteit ovarium | tuba,TC101,M16,SC7,DTC322158,51.0,384,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-01 09:00:00,0.0,9.0,3.0,9.0,50198400.0,0.0,1
48887,maligniteit endometrium,TC3101,DC823,SC13,DTC309433,58.0,387,AC419100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2005-09-05 09:00:00,0.0,9.0,0.0,9.0,25056000.0,0.0,1
49121,maligniteit vulva,TC101,M11,SC7,other,86.0,390,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-07 09:00:00,0.0,9.0,2.0,9.0,64108800.0,0.0,1
49153,Gynaecologische tumoren,TC61,DC106,SC7,DTC363167,89.0,391,AC415100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-07 09:00:00,0.0,9.0,2.0,9.0,79833600.0,0.0,1
49396,Maligne neoplasma cervix uteri,TC103,DC822,SC61,DTC313464,44.0,395,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-07 09:00:00,0.0,9.0,2.0,9.0,33264000.0,0.0,1
49629,maligniteit ovarium | tuba,TC101,M16,SC7,DTC303420,51.0,397,AC10107,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-07 09:00:00,0.0,9.0,2.0,9.0,42336000.0,0.0,1
50121,Gynaecologische tumoren,TC13,DC106,SC61,DTC391454,45.0,403,AC378546,LBAC,Section 4,SC87,Medical Microbiology,1.0,2005-09-08 09:00:00,0.0,9.0,3.0,9.0,57369600.0,0.0,1
50453,maligniteit myometrium,TC101,M15,SC7,other,57.0,407,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-12 09:00:00,0.0,9.0,0.0,9.0,24364800.0,0.0,1
50456,maligniteit ovarium | tuba,TC101,M16,SC7,other,60.0,408,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-12 09:00:00,0.0,9.0,0.0,9.0,0.0,0.0,1
50464,maligniteit cervix,TC101,M13,SC7,other,75.0,410,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-14 09:00:00,0.0,9.0,2.0,9.0,0.0,0.0,1
50942,maligniteit vulva,TC803,M11,SC7,DTC312565,74.0,417,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-19 09:00:00,0.0,9.0,0.0,9.0,29203200.0,0.0,1
51521,maligniteit cervix,TC101,M13,SC7,other,47.0,425,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-22 09:00:00,0.0,9.0,3.0,9.0,32054400.0,0.0,1
51641,maligniteit cervix,TC101,M13,SC7,other,74.0,431,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-28 09:00:00,0.0,9.0,2.0,9.0,0.0,0.0,1
51879,maligniteit vulva,TC813,M11,SC7,DTC320583,82.0,432,AC20189,H1NO,Section 3,SC89,Recovery room / high care,1.0,2005-09-29 09:00:00,0.0,9.0,3.0,9.0,74390400.0,0.0,1
52025,maligniteit vulva,TC101,M11,SC7,DTC368248,52.0,434,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-29 09:00:00,0.0,9.0,3.0,9.0,75427200.0,0.0,1
52029,maligniteit cervix,TC101,M13,SC7,other,36.0,435,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-29 09:00:00,0.0,9.0,3.0,9.0,34473600.0,0.0,1
52034,maligniteit ovarium | tuba,TC101,M16,SC7,other,73.0,436,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-29 09:00:00,0.0,9.0,3.0,9.0,64713600.0,0.0,1
52193,Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC333226,44.0,440,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-10-03 09:00:00,0.0,10.0,0.0,9.0,41126400.0,0.0,1
52694,maligniteit cervix,TC101,M13,SC7,other,62.0,445,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-05 09:00:00,0.0,10.0,2.0,9.0,0.0,0.0,1
53163,maligniteit vulva,TC3303,DC839,SC13,DTC383910,83.0,448,other,other,Section 6,SC13,other,1.0,2005-10-07 09:00:00,0.0,10.0,4.0,9.0,4060800.0,0.0,1
53274,maligniteit cervix,TC101,M13,SC7,DTC334664,36.0,450,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-10 09:00:00,0.0,10.0,0.0,9.0,71107200.0,0.0,1
53718,maligniteit cervix,TC101,M13,SC7,other,73.0,455,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-17 09:00:00,0.0,10.0,0.0,9.0,0.0,0.0,1
54213,maligniteit cervix,TC101,M13,SC7,other,53.0,462,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-19 09:00:00,0.0,10.0,2.0,9.0,0.0,0.0,1
54463,maligniteit cervix,TC101,M13,SC7,other,80.0,465,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-24 09:00:00,0.0,10.0,0.0,9.0,35251200.0,0.0,1
55429,maligniteit cervix,TC101,M13,SC7,other,40.0,469,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-26 09:00:00,0.0,10.0,2.0,9.0,15724800.0,0.0,1
55548,maligniteit cervix,TC101,M13,SC7,other,39.0,473,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-27 09:00:00,0.0,10.0,3.0,9.0,39312000.0,0.0,1
55628,Metastasen corpus maligniteit uteri (nno),TC603,M14,SC7,DTC339513,47.0,474,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-10-27 09:00:00,0.0,10.0,3.0,9.0,70761600.0,0.0,1
55660,maligniteit ovarium | tuba,TC103,M16,SC7,DTC339319,55.0,475,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-10-27 09:00:00,0.0,10.0,3.0,9.0,777600.0,0.0,1
56264,maligniteit cervix,TC803,M13,SC7,DTC343853,60.0,481,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-03 09:00:00,0.0,11.0,3.0,9.0,19958400.0,0.0,1
56339,maligniteit cervix,TC3301,DC822,SC13,DTC345666,61.0,483,370403S,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-07 09:00:00,0.0,11.0,0.0,9.0,1987200.0,0.0,1
56368,maligniteit vulva,TC101,M11,SC7,other,81.0,485,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-09 09:00:00,0.0,11.0,2.0,9.0,64108800.0,0.0,1
56408,maligniteit cervix,TC101,M13,SC7,other,44.0,488,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-09 09:00:00,0.0,11.0,2.0,9.0,70761600.0,0.0,1
56790,maligniteit ovarium | tuba,TC101,M16,SC7,other,83.0,491,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-09 09:00:00,0.0,11.0,2.0,9.0,38707200.0,0.0,1
56952,maligniteit cervix,TC101,M13,SC7,other,53.0,493,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-10 09:00:00,0.0,11.0,3.0,9.0,32054400.0,0.0,1
57868,maligniteit vulva,TC803,M11,SC7,DTC351086,82.0,496,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-14 09:00:00,0.0,11.0,0.0,9.0,3283200.0,0.0,1
57926,Gynaecologische tumoren,TC61,DC106,SC7,DTC352851,44.0,498,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-16 09:00:00,0.0,11.0,2.0,9.0,66355200.0,0.0,1
58173,maligniteit cervix,TC103,M13,SC7,DTC355699,70.0,501,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-21 09:00:00,0.0,11.0,0.0,9.0,6652800.0,0.0,1
58241,maligniteit ovarium | tuba,TC803,M16,SC7,DTC355558,50.0,502,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-21 09:00:00,0.0,11.0,0.0,9.0,9936000.0,0.0,1
58340,maligniteit vulva,TC503,M11,SC7,DTC359445,70.0,504,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-24 09:00:00,0.0,11.0,3.0,9.0,48124800.0,0.0,1
58367,Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC359799,35.0,505,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-24 09:00:00,0.0,11.0,3.0,9.0,68342400.0,0.0,1
58662,maligniteit cervix,TC101,M13,SC7,DTC373622,35.0,508,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-29 09:00:00,0.0,11.0,1.0,9.0,18835200.0,0.0,1
58764,maligniteit cervix,TC103,M13,SC7,DTC363510,88.0,509,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2005-11-30 09:00:00,0.0,11.0,2.0,9.0,10886400.0,0.0,1
58867,Ongediff. adenoca. ovarium st IIIc,TC803,M16,SC7,DTC363618,69.0,511,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-30 09:00:00,0.0,11.0,2.0,9.0,1296000.0,0.0,1
63028,Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC383467,48.0,525,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-12-14 09:00:00,0.0,12.0,2.0,9.0,63504000.0,0.0,1
63625,Maligne neoplasma cervix uteri,TC61,DC106,SC61,DTC392802,38.0,526,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-14 09:00:00,0.0,12.0,2.0,9.0,56332800.0,0.0,1
63664,maligniteit endometrium,TC101,M14,SC7,other,79.0,528,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-12-19 09:00:00,0.0,12.0,0.0,9.0,65577600.0,0.0,1
64138,maligniteit cervix,TC803,M13,SC7,DTC379572,55.0,531,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-21 09:00:00,0.0,12.0,2.0,9.0,69552000.0,0.0,1
65031,maligniteit cervix,TC113,M13,SC61,DTC393928,62.0,533,370401S,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-23 09:00:00,0.0,12.0,4.0,9.0,8726400.0,0.0,1
67483,maligniteit vagina,TC113,M12,SC7,DTC385086,63.0,538,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2005-12-30 09:00:00,0.0,12.0,4.0,9.0,59097600.0,0.0,1
67828,maligniteit cervix,TC103,M13,SC61,DTC386013,36.0,539,AC419100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-01-02 09:00:00,0.0,1.0,0.0,9.0,31104000.0,0.0,1
69447,Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC392898,41.0,543,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-04 09:00:00,0.0,1.0,2.0,9.0,55728000.0,0.0,1
69479,maligniteit cervix,TC61,DC106,SC61,other,68.0,545,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-01-05 09:00:00,0.0,1.0,3.0,9.0,25920000.0,0.0,1
69698,Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC394833,74.0,548,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-11 09:00:00,0.0,1.0,2.0,9.0,65836800.0,0.0,1
70250,Gynaecologische tumoren,TC13,DC106,SC7,DTC394447,68.0,549,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-11 09:00:00,0.0,1.0,2.0,9.0,68256000.0,0.0,1
70472,maligniteit endometrium,TC101,M14,SC7,other,74.0,552,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-11 09:00:00,0.0,1.0,2.0,9.0,25401600.0,0.0,1
70641,maligniteit ovarium | tuba,TC101,M16,SC7,DTC395261,81.0,555,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-12 09:00:00,0.0,1.0,3.0,9.0,0.0,0.0,1
70862,maligniteit cervix,TC101,M13,SC61,DTC575145,91.0,558,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-01-16 09:00:00,0.0,1.0,0.0,9.0,21168000.0,0.0,1
71139,Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC438856,46.0,559,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-16 09:00:00,0.0,1.0,0.0,9.0,35251200.0,0.0,1
71346,maligniteit cervix,TC803,M13,SC7,DTC399410,41.0,560,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-18 09:00:00,0.0,1.0,2.0,9.0,19180800.0,0.0,1
71385,maligniteit cervix,TC101,M13,SC7,DTC398986,38.0,561,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-18 09:00:00,0.0,1.0,2.0,9.0,33868800.0,0.0,1
72159,maligniteit myometrium,TC803,M15,SC61,DTC574624,63.0,565,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-18 09:00:00,0.0,1.0,2.0,9.0,23587200.0,0.0,1
72198,maligniteit cervix,TC101,M13,SC7,other,40.0,567,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-19 09:00:00,0.0,1.0,3.0,9.0,65923200.0,0.0,1
72206,Gynaecologische tumoren,TC61,DC106,SC7,other,59.0,568,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-01-19 09:00:00,0.0,1.0,3.0,9.0,56332800.0,0.0,1
72249,maligniteit ovarium | tuba,TC101,M16,SC7,DTC400130,46.0,570,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-19 09:00:00,0.0,1.0,3.0,9.0,60480000.0,0.0,1
72886,maligniteit cervix,TC101,M13,SC7,other,38.0,573,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-25 09:00:00,0.0,1.0,2.0,9.0,64627200.0,0.0,1
73894,maligniteit vulva,TC101,M11,SC7,other,81.0,583,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-01 09:00:00,0.0,2.0,2.0,9.0,37497600.0,0.0,1
74412,maligniteit ovarium | tuba,TC101,M16,SC7,DTC406503,34.0,587,372440A,SLVE,Section 4,SC86,Special lab radiology,1.0,2006-02-01 09:00:00,0.0,2.0,2.0,9.0,54432000.0,0.0,1
75119,Maligne nieuwvormingen corpus uteri (ov),TC13,DC106,SC61,DTC574868,83.0,592,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-08 09:00:00,0.0,2.0,2.0,9.0,4406400.0,0.0,1
75855,Plav.celcarc. vulva: st IVa,TC113,M11,SC61,DTC434512,82.0,596,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-13 09:00:00,0.0,2.0,0.0,9.0,8726400.0,0.0,1
76148,maligniteit ovarium | tuba,TC803,M16,SC7,DTC416155,76.0,597,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-13 09:00:00,0.0,2.0,0.0,9.0,24537600.0,0.0,1
76285,Plaveiselcelcarinoom vulva (nno),TC103,M11,SC7,DTC405039,74.0,600,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-15 09:00:00,0.0,2.0,2.0,9.0,58060800.0,0.0,1
76318,maligniteit cervix,TC101,M13,SC7,other,51.0,605,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-16 09:00:00,0.0,2.0,3.0,9.0,7257600.0,0.0,1
76604,Gynaecologische tumoren,TC61,DC106,SC7,DTC418694,62.0,607,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-16 09:00:00,0.0,2.0,3.0,9.0,61084800.0,0.0,1
76618,maligniteit vulva,TC101,M11,SC7,other,68.0,609,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-23 09:00:00,0.0,2.0,3.0,9.0,53568000.0,0.0,1
76719,maligniteit vulva,TC803,M11,SC7,DTC423382,84.0,610,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-23 09:00:00,0.0,2.0,3.0,9.0,29548800.0,0.0,1
76749,maligniteit cervix,TC101,M13,SC7,other,38.0,611,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-23 09:00:00,0.0,2.0,3.0,9.0,33264000.0,0.0,1
76753,maligniteit cervix,TC101,M13,SC7,other,42.0,612,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-23 09:00:00,0.0,2.0,3.0,9.0,34473600.0,0.0,1
76761,maligniteit endometrium,TC101,M14,SC7,DTC423064,59.0,613,378619A,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-23 09:00:00,0.0,2.0,3.0,9.0,54345600.0,0.0,1
77077,maligniteit cervix,TC113,M13,SC7,DTC427950,52.0,618,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-02 09:00:00,0.0,3.0,3.0,9.0,604800.0,0.0,1
78025,Maligne neoplasma cervix uteri,TC61,DC822,SC61,DTC443333,41.0,622,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-07 09:00:00,0.0,3.0,1.0,9.0,63763200.0,0.0,1
79514,maligniteit endometrium,TC703,M14,SC7,DTC431739,65.0,626,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-08 09:00:00,0.0,3.0,2.0,9.0,3542400.0,0.0,1
80348,maligniteit vagina,TC103,M12,SC7,DTC475355,85.0,631,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-13 09:00:00,0.0,3.0,0.0,9.0,7344000.0,0.0,1
80833,Gynaecologische tumoren,TC23,DC106,SC61,DTC785440,78.0,636,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-14 09:00:00,0.0,3.0,1.0,9.0,53395200.0,0.0,1
80915,maligniteit vulva,TC603,M11,SC61,DTC575456,79.0,637,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-15 09:00:00,0.0,3.0,2.0,9.0,17712000.0,0.0,1
80978,maligniteit cervix,TC101,DC106,SC7,other,74.0,641,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-15 09:00:00,0.0,3.0,2.0,9.0,63417600.0,0.0,1
82039,maligniteit vagina,TC101,M12,SC7,DTC440812,82.0,648,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-22 09:00:00,0.0,3.0,2.0,9.0,0.0,0.0,1
82070,maligniteit cervix,TC101,M13,SC7,other,40.0,649,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-22 09:00:00,0.0,3.0,2.0,9.0,2419200.0,0.0,1
82075,maligniteit cervix,TC61,DC106,SC61,other,42.0,650,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-22 09:00:00,0.0,3.0,2.0,9.0,23673600.0,0.0,1
82202,maligniteit myometrium,TC101,M15,SC7,other,63.0,652,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-22 09:00:00,0.0,3.0,2.0,9.0,32054400.0,0.0,1
82643,maligniteit ovarium | tuba,TC101,M16,SC7,other,40.0,654,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-22 09:00:00,0.0,3.0,2.0,9.0,0.0,0.0,1
83671,"Plaveiselcelca, cervix st Ia2",TC803,M13,SC7,DTC549744,40.0,668,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-05 09:00:00,0.0,4.0,2.0,9.0,47174400.0,0.0,1
84132,Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC450231,75.0,670,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-04-05 09:00:00,0.0,4.0,2.0,9.0,3283200.0,0.0,1
84221,Recidieven corpus maligniteit uteri (nno),TC803,M14,SC7,DTC451132,63.0,671,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-04-06 09:00:00,0.0,4.0,3.0,9.0,58060800.0,0.0,1
85007,Gynaecologische tumoren,TC61,DC106,SC7,other,72.0,677,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-12 09:00:00,0.0,4.0,2.0,9.0,43545600.0,0.0,1
85515,Maligne neoplasma ovarium,TC3101,DC821,SC13,DTC464275,61.0,678,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-04-12 09:00:00,0.0,4.0,2.0,9.0,60307200.0,0.0,1
85658,maligniteit ovarium | tuba,TC803,M16,SC7,DTC456784,68.0,680,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-04-13 09:00:00,0.0,4.0,3.0,9.0,2419200.0,0.0,1
85842,maligniteit vulva,TC101,M11,SC7,other,62.0,682,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-19 09:00:00,0.0,4.0,2.0,9.0,50198400.0,0.0,1
86257,maligniteit ovarium | tuba,TC102,M16,SC7,DTC458989,27.0,687,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-19 09:00:00,0.0,4.0,2.0,9.0,49593600.0,0.0,1
86307,maligniteit myometrium,TC101,M15,SC7,other,58.0,690,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-27 09:00:00,0.0,4.0,3.0,9.0,49507200.0,0.0,1
86893,maligniteit ovarium | tuba,TC101,M16,SC7,DTC470100,65.0,695,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-04 09:00:00,0.0,5.0,3.0,9.0,6739200.0,0.0,1
87243,maligniteit vulva,TC101,M11,SC7,DTC473750,86.0,700,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-10 09:00:00,0.0,5.0,2.0,9.0,48988800.0,0.0,1
87245,"Plaveiselcelca, cervix st Ib",TC101,M13,SC7,other,71.0,701,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-10 09:00:00,0.0,5.0,2.0,9.0,0.0,0.0,1
88133,Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC491400,59.0,711,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-17 09:00:00,0.0,5.0,2.0,9.0,39744000.0,0.0,1
88161,maligne nieuwvormingen vulva (nno),TC101,M11,SC7,other,84.0,712,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-18 09:00:00,0.0,5.0,3.0,9.0,0.0,0.0,1
88349,"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC481124,41.0,716,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-19 09:00:00,0.0,5.0,4.0,9.0,28166400.0,0.0,1
88734,Gynaecologische tumoren,TC603,DC106,SC61,DTC785367,68.0,720,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-24 09:00:00,0.0,5.0,2.0,9.0,53913600.0,0.0,1
89282,Maligne neoplasma cervix uteri,TC3201,M13,SC61,DTC500735,80.0,723,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2006-05-29 09:00:00,0.0,5.0,0.0,9.0,19612800.0,0.0,1
89993,"Plaveiselcelca, cervix st Ib",TC503,M13,SC7,DTC543244,35.0,726,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-06-02 09:00:00,0.0,6.0,4.0,9.0,5356800.0,0.0,1
90009,Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC575385,68.0,727,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-06-02 09:00:00,0.0,6.0,4.0,9.0,3542400.0,0.0,1
90220,Plav.celcarc. vulva: (st onbekend),TC101,M11,SC7,other,64.0,729,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-06-07 09:00:00,0.0,6.0,2.0,9.0,0.0,0.0,1
91025,Gynaecologische tumoren,TC61,DC106,SC7,DTC495023,53.0,736,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-12 09:00:00,0.0,6.0,0.0,9.0,31708800.0,0.0,1
91640,Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-14 09:00:00,0.0,6.0,2.0,9.0,36288000.0,0.0,1
92993,Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-19 09:00:00,0.0,6.0,0.0,9.0,14688000.0,0.0,1
93074,Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-06-19 09:00:00,0.0,6.0,0.0,9.0,34646400.0,0.0,1
94377,maligniteit vulva,TC101,M11,SC7,other,67.0,751,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-28 09:00:00,0.0,6.0,2.0,9.0,35251200.0,0.0,1
94582,"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-30 09:00:00,0.0,6.0,4.0,9.0,16848000.0,0.0,1
94636,maligniteit endometrium,TC61,DC106,SC61,other,49.0,762,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-05 09:00:00,0.0,7.0,2.0,9.0,21859200.0,0.0,1
95224,maligniteit cervix,TC101,M13,SC7,other,49.0,765,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-06 09:00:00,0.0,7.0,3.0,9.0,0.0,0.0,1
95450,"Plaveiselcelca, cervix st Ib",TC101,M13,SC7,other,47.0,768,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-12 09:00:00,0.0,7.0,2.0,9.0,0.0,0.0,1
95458,Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 09:00:00,0.0,7.0,2.0,9.0,518400.0,0.0,1
95575,maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-13 09:00:00,0.0,7.0,3.0,9.0,13219200.0,0.0,1
95821,maligniteit vulva,TC101,M11,SC7,other,74.0,775,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-19 09:00:00,0.0,7.0,2.0,9.0,0.0,0.0,1
95898,Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2006-07-19 09:00:00,0.0,7.0,2.0,9.0,52617600.0,0.0,1
95905,Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,375003A,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-19 09:00:00,0.0,7.0,2.0,9.0,604800.0,0.0,1
95944,"Plaveiselcelca, cervix st IIIb",TC101,M13,SC7,DTC524974,66.0,778,AC355409,LVPT,Section 4,SC88,Pathology,1.0,2006-07-20 09:00:00,0.0,7.0,3.0,9.0,518400.0,0.0,1
95971,Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-21 09:00:00,0.0,7.0,4.0,9.0,604800.0,0.0,1
96014,Gynaecologische tumoren,TC61,DC106,SC7,DTC525955,40.0,781,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-24 09:00:00,0.0,7.0,0.0,9.0,36288000.0,0.0,1
96860,maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-31 09:00:00,0.0,7.0,0.0,9.0,0.0,0.0,1
98392,maligniteit endometrium,TC101,M14,SC7,other,74.0,799,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-21 09:00:00,0.0,8.0,0.0,9.0,0.0,0.0,1
99733,maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-21 09:00:00,0.0,8.0,0.0,9.0,6393600.0,0.0,1
100067,Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-23 09:00:00,0.0,8.0,2.0,9.0,46569600.0,0.0,1
100095,maligniteit ovarium | tuba,TC101,M16,SC7,other,67.0,802,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-23 09:00:00,0.0,8.0,2.0,9.0,0.0,0.0,1
100105,maligniteit ovarium | tuba,TC101,M16,SC7,DTC545423,39.0,803,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-08-24 09:00:00,0.0,8.0,3.0,9.0,44150400.0,0.0,1
100455,maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-25 09:00:00,0.0,8.0,4.0,9.0,432000.0,0.0,1
100776,maligniteit endometrium,TC61,DC106,SC61,other,45.0,808,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-30 09:00:00,0.0,8.0,2.0,9.0,16416000.0,0.0,1
101759,Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-01 09:00:00,0.0,9.0,4.0,9.0,20563200.0,0.0,1
101798,"Plaveiselcelca, cervix st IIb",TC61,DC106,SC61,DTC795001,57.0,812,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-04 09:00:00,0.0,9.0,0.0,9.0,16934400.0,0.0,1
101861,Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 09:00:00,0.0,9.0,0.0,9.0,47952000.0,0.0,1
103187,"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-08 09:00:00,0.0,9.0,4.0,9.0,33177600.0,0.0,1
103246,maligniteit endometrium,TC13,DC106,SC61,DTC785637,85.0,818,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-11 09:00:00,0.0,9.0,0.0,9.0,6912000.0,0.0,1
105427,Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 09:00:00,0.0,9.0,1.0,9.0,44236800.0,0.0,1
106331,"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-26 09:00:00,0.0,9.0,1.0,9.0,17625600.0,0.0,1
106824,maligniteit cervix,TC101,M13,SC7,other,38.0,831,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-04 09:00:00,0.0,10.0,2.0,9.0,0.0,0.0,1
107388,Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-13 09:00:00,0.0,10.0,4.0,9.0,32486400.0,0.0,1
107417,Recidieven corpus maligniteit uteri (nno),TC101,M14,SC7,other,50.0,835,other,LVPT,Section 4,SC88,Pathology,1.0,2006-10-18 09:00:00,0.0,10.0,2.0,9.0,0.0,0.0,1
107637,Adenoca: corpus uteri st IIIb,TC703,M14,SC7,DTC584816,71.0,836,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-18 09:00:00,0.0,10.0,2.0,9.0,30067200.0,0.0,1
107860,maligne nieuwvormingen vulva (nno),TC101,M11,SC7,other,80.0,839,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-26 09:00:00,0.0,10.0,3.0,9.0,0.0,0.0,1
108066,Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-10-30 09:00:00,0.0,10.0,0.0,9.0,39484800.0,0.0,1
108528,Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2006-11-06 09:00:00,0.0,11.0,0.0,9.0,16934400.0,0.0,1
109932,"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2006-11-13 09:00:00,0.0,11.0,0.0,9.0,31017600.0,0.0,1
111290,"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-20 09:00:00,0.0,11.0,0.0,9.0,29635200.0,0.0,1
111365,Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-20 09:00:00,0.0,11.0,0.0,9.0,7257600.0,0.0,1
112115,Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 09:00:00,0.0,12.0,3.0,9.0,25401600.0,0.0,1
112149,maligniteit ovarium | tuba,TC101,M16,SC7,other,58.0,869,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-07 09:00:00,0.0,12.0,3.0,9.0,86400.0,0.0,1
112579,Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 09:00:00,0.0,12.0,0.0,9.0,35078400.0,0.0,1
112702,Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 09:00:00,0.0,12.0,2.0,9.0,7689600.0,0.0,1
112973,Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 09:00:00,0.0,12.0,3.0,9.0,39312000.0,0.0,1
113156,"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-15 09:00:00,0.0,12.0,4.0,9.0,35510400.0,0.0,1
113226,Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 09:00:00,0.0,12.0,2.0,9.0,8553600.0,0.0,1
113797,Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,other,LVPT,Section 4,SC88,Pathology,1.0,2006-12-27 09:00:00,0.0,12.0,2.0,9.0,35078400.0,0.0,1
114074,Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 09:00:00,0.0,1.0,2.0,9.0,32745600.0,0.0,1
114236,Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 09:00:00,0.0,1.0,0.0,9.0,31622400.0,0.0,1
114749,Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787923,70.0,887,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-17 09:00:00,0.0,1.0,2.0,9.0,31449600.0,0.0,1
114853,Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 09:00:00,0.0,1.0,2.0,9.0,27734400.0,0.0,1
116733,Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 09:00:00,0.0,1.0,2.0,9.0,9676800.0,0.0,1
117291,"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-12 09:00:00,0.0,2.0,0.0,9.0,28598400.0,0.0,1
118845,Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 09:00:00,0.0,2.0,0.0,9.0,27302400.0,0.0,1
119058,maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 09:00:00,0.0,2.0,1.0,9.0,30931200.0,0.0,1
119659,Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-28 09:00:00,0.0,2.0,2.0,9.0,518400.0,0.0,1
